entertainment -WSS

entertainment

author：hotspot 2025-09-27 10:03:01 - browse：8213

Illustration of a prescription bottle image on the screen of a smart phone – medical tech coverage from STAT — Alex Hogan/STAT

In another sign of the business headwinds facing prescription mental health apps, developer Twill will shop around for a pharmaceutical company to market Aspiro, its cognitive behavioral therapy treatment for both generalized anxiety and major depression.

Twill executives told STAT the company hopes that a drugmaker developing or currently marketing a product for generalized anxiety, or GAD, and major depressive disorder, or MDD, will be interested in adding a digital therapeutic to boost the effect of its drug — as well as its sales. Twill’s chief strategy officer Chris Wasden said that after watching companies built around prescription digital therapeutics, or PDTs, stall out, Twill made the decision earlier this year that it would only take the product to market if it found a willing drugmaker to serve as its partner.

“A PDT is going to be more valuable in the hands of a drug company that has a drug that they would like to get greater adherence [and] greater revenues from rather than trying to get reimbursement for the PDT itself,” he said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： The FDA weighs the risks of candy

focus

WSS

CDC recommends rationing of RSV shot due to shortages

Readout Newsletter: New research from Sanofi, Regeneron, etc.

HHS secretary Becerra pressed on Change HealthCare cyberattack

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Male and female sex labels in research insufficient, scientists say

Pushing for an NIH office for post

focus

entertainment

explore

Hollywood unions extend contract negotiations for actors

Medicare coverage of Wegovy, once blocked, now looks possible

Sports medicine is finally prioritizing gender equality

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

As demand for Covid shots wanes, Moderna seeks its next success

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Cancer drug shortages should be causing more outrage

Amid AI frenzy, a top HHS official's quest to create safeguards

Walensky prepares to leave CDC — and Congress — behind

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

explore

Ebola: Gilead Sciences antiviral shows promise as new treatment

RaDonda Vaught links Vanderbilt hospital issues to patient death

Readout Newsletter: CAR

Maker of FluMist seeks to allow at

Diversifying clinical trials isn't enough to close racial gaps: study

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

entertainment

focus

entertainment

Wikipedia